You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 2, February 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of {varepsilon}-Aminocaproic Acid on Postvitrectomy Hemorrhage

Serge de Bustros, MD; Bert M. Glaser, MD; Ronald G. Michels, MD; Cheryl Auer, MS

Arch Ophthalmol. 1985;103(2):219-221.


Abstract

• We performed a prospective study involving 96 patients undergoing vitrectomy for proliferative diabetic retinopathy to determine the effect of {varepsilon}-aminocaproic acid on the occurrence of postoperative intraocular hemorrhage. {varepsilon}-Aminocaproic acid significantly reduced postoperative vitreous hemorrhage during the immediate postoperative period. Follow-up examinations two to six weeks after discharge from the hospital disclosed no statistically significant difference in the severity of vitreous hemorrhage between the treated and untreated groups. The loss of drug effect at this stage was in part due to spontaneous repeated bleeding in the treated group and in part to spontaneous clearing of hemorrhage in the untreated group. There was no statistically significant difference in the rate of repeated bleeding between the two groups or in rate of spontaneous clearing.



Author Affiliations

From the Center for Vitreoretinal Research (Drs de Bustros, Glaser, and Michels) and the Biostatistical Center (Ms Auer), Wilmer Institute, The Johns Hopkins Hospital, Baltimore. Dr de Bustros is a fellow for Research to Prevent Blindness Inc, New York.


Footnotes

Accepted for publication Oct 26, 1984.

Read in part before the American Academy of Ophthalmology meeting, Atlanta, Nov 12, 1984.

Reprint requests to The Johns Hopkins Hospital, 600 N Wolfe St, Maumenee 119, Baltimore, MD 21205 (Dr Glaser).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial
Ramezani et al.
Br J Ophthalmol 2005;89:1041-1044.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.